Outlook Therapeutics, Inc. OTLK · Transcripts

17

Outlook Therapeutics, Inc. is a biopharmaceutical company in the advanced stages of clinical develop...

Price0.4593

Market Cap107.12 M

Float217.86 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login